Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Solid Tumors and Hematological Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02431260
What this trial is testing

An Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced Malignancies

Who this might be right for
Solid Tumors and Hematologic Malignancy
Incyte Corporation 69
Early research (Phase 1)Looking for participantsNCT06484816
What this trial is testing

TGRX-1942 Chinese Phase I for Advanced Solid Tumor And/or Relapsed/Refractory Hematologic Malignancies

Who this might be right for
Non Small Cell Lung CancerAdvanced Solid TumorHematologic Malignancy
Shenzhen TargetRx Co., Ltd. 90
Early research (Phase 1)Ended earlyNCT00089089
What this trial is testing

Decitabine in Treating Patients With Advanced Refractory Solid Tumors or Lymphomas

Who this might be right for
Hematopoietic/Lymphoid CancerUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439188
What this trial is testing

Testing GSK2636771 as a Potential Targeted Treatment in Cancers With PTEN Loss of Expression (MATCH-Subprotocol P)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 35
Early research (Phase 1)Ended earlyNCT04305249
What this trial is testing

Safety and Preliminary Efficacy of ATG-017 Monotherapy or Combination Therapy With Nivolumab in Advanced Solid Tumors and Hematological Malignancies

Who this might be right for
Solid TumorHematological Malignancy
Antengene Therapeutics Limited 36
Early research (Phase 1)Study completedNCT00741234
What this trial is testing

A Phase I Dose Escalation Study of Oral SB939 Administered Alone or With Azacitidine

Who this might be right for
Solid TumorsHematologic MalignanciesMyelodysplastic Syndrome
S*BIO 85
Early research (Phase 1)Study completedNCT00008125
What this trial is testing

Combination Chemotherapy With or Without Filgrastim in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
University of Pittsburgh 25
Not applicableLooking for participantsNCT02534649
What this trial is testing

Bergonie Institut Profiling : Fighting Cancer by Matching Molecular Alterations and Drugs in Early Phase Trials

Who this might be right for
Solid TumorHematological Malignancy
Institut Bergonié 10,000
Testing effectiveness (Phase 2)Study completedNCT04439240
What this trial is testing

Testing AZD4547 as a Potential Targeted Treatment in Cancers With FGFR Genetic Changes (MATCH-Subprotocol W)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 52
Not applicableStudy completedNCT01869218
What this trial is testing

Feasibility Study of Genomic Sequencing to Find Potential Targets for Personalized Therapy

Who this might be right for
Hematologic Neoplasms
University of Colorado, Denver 40
Not applicableStudy completedNCT03222258
What this trial is testing

Prospective Cohort Study Depending on the Use of Palliative Care for Advanced Stage of Cancer Patients

Who this might be right for
Stage IV Breast CancerStage IV Pancreatic CancerStage IV Colon Cancer+9 more
Seoul National University Hospital 444
Early research (Phase 1)Study completedNCT03512340
What this trial is testing

Study of SRF231 in Patients With Advanced Solid and Hematologic Cancers

Who this might be right for
Advanced Solid CancersHematologic Cancers
Surface Oncology 148
Early research (Phase 1)Study completedNCT00840190
What this trial is testing

Selective Cyclin Dependent Kinase Inhibitor P1446A-05 In Subjects With Advanced Refractory Malignancies

Who this might be right for
Solid TumorHematologic Malignancy
Piramal Enterprises Limited 29
Early research (Phase 1)UnknownNCT00710697
What this trial is testing

Cardiac Safety Assessment Study of Picoplatin in Solid Tumors

Who this might be right for
Solid Tumors
Poniard Pharmaceuticals 40
Early research (Phase 1)Study completedNCT02492789
What this trial is testing

A Trial to Evaluate Safety and Tolerability of INCSHR01210 in Cancer Patients

Who this might be right for
Solid Tumors and Hematologic Malignancy
Atridia Pty Ltd. 49
Early research (Phase 1)Ended earlyNCT00915278
What this trial is testing

A Safety Study Of A Monoclonal Antibody Against A5B1 Integrin In Solid Tumors

Who this might be right for
Advanced Non-Hematologic Malignancies
Pfizer 33
Not applicableTemporarily pausedNCT05091632
What this trial is testing

Assessment of Verbal Comprehension and Cognitive Processes in Patients Admitted to the Palliative and Supportive Care Unit

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmLocally Advanced Malignant Solid NeoplasmMetastatic Malignant Solid Neoplasm+1 more
M.D. Anderson Cancer Center 30
Early research (Phase 1)Study completedNCT03386526
What this trial is testing

APG-1387 in Patients With Advanced Solid Tumors or Hematologic Malignancies

Who this might be right for
Advanced Solid Tumors or Hematologic Malignancies
Ascentage Pharma Group Inc. 90
Early research (Phase 1)WithdrawnNCT00820768
What this trial is testing

A Trial of ABI-010 & ABI-007 in Patients With Advanced Non-Hematologic Malignancies

Who this might be right for
Solid Tumor
Celgene
Early research (Phase 1)Study completedNCT01195311
What this trial is testing

A Dose-escalation Study in Subjects With Advanced Malignancies

Who this might be right for
Solid Tumors and Hematologic Malignancy
Incyte Corporation 52
Next Page